OCUGEN, INC. Property, Plant and Equipment, Gross
OCUGEN, INC. (OCGN) had Property, Plant and Equipment, Gross of $20.02 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Gross $20.02M.
- 2026-03-31: Property, Plant and Equipment, Gross $19.93M.
- 2025-12-31: Property, Plant and Equipment, Gross $19.91M.
- 2025-09-30: Property, Plant and Equipment, Gross $19.87M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $20.02M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $19.93M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $19.91M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $19.87M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $19.78M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $19.74M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $19.71M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $19.70M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $19.44M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $19.05M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $18.52M 10-K · filed 2025-03-05 | |
| 2023-09-30 | $15.53M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $12.61M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $8.74M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $6.67M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $5.09M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $3.67M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $2.36M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $1.54M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $988.00K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $859.00K 10-Q · filed 2021-05-07 | $858.66K 10-K · filed 2021-03-19 |
| 2019-12-31 | $348.51K 10-K · filed 2021-03-19 | |
| 2019-03-31 | $10.25M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $10.43M 10-Q · filed 2019-08-09 | |
| 2018-09-30 | $15.63M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $16.41M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $15.54M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $13.64M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $13.38M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $13.32M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $13.28M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $13.25M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $13.52M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $13.52M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $13.23M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $13.20M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $13.07M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $12.57M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $12.17M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $11.25M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |